The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Pathogenesis and Treatment of Hepatorenal Syndrome
Abstract
Hepatorenal syndrome (HRS) is a functional renal failure that frequently develops in patients with advanced cirrhosis and severe impairment in systemic circulatory function. Traditionally it has been considered to be the consequence of a progression of the splanchnic arterial vasodilation occurring in these patients. However, recent data indicate that a reduction in cardiac output also plays a significant role. There are two different types of HRS. Type-2 HRS consists of a moderate and steady or slowly progressive renal failure. It represents the extreme expression of the circulatory dysfunction that spontaneously develops in patients with cirrhosis. The main clinical problem in these patients is refractory ascites. Type-1 HRS is a rapidly progressive acute renal failure that frequently develops in closed temporal relationship with a precipitating event, commonly spontaneous bacterial peritonitis. In addition to renal failure, patients with type-1 HRS present deterioration in the function of other organs, including the heart, brain, liver, and adrenal glands. Type-1 HRS is the complication of cirrhosis associated with the worst prognosis. However, effective treatments of HRS (vasoconstrictors associated with intravenous albumin, transjugular intrahepatic portacaval shunt, albumin dialysis) that can improve survival have recently been introduced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fernández, J., Navasa, M., Planas, R., Montoliu, S., Monfort, D., Soriano, G., Vila, C., Pardo, A., Quintero, E., Vargas, V., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.065 · Cited by 709 · cited 1×
“The second study was performed in cirrhotic patients at a high risk of developing SBP and type-1 HRS.(91) Primary prophylaxis of SBP using long-term oral norfloxacin was given to 35 patients with low protein ascites (< 15 g/L) and advanced liver failure (Child-Pugh score 9 points with serum bilirubin 3 mg/dL) or impai…”
BackgroundSelf-citation
Cited by
Acute kidney injury in cirrhosis
Garcia-Tsao, G., Parikh, C. R., & Viola, A. (2008) · Hepatology · doi:10.1002/hep.22605 · Cited by 662
Management of bacterial infections in cirrhosis
Fernández, J., & Gustot, T. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60002-6 · Cited by 368
Global Consequences of Liver Ischemia/Reperfusion Injury
Nastos, C., Kalimeris, K., Papoutsidakis, N., Tasoulis, M.-K., Lykoudis, P. M., Theodoraki, K., Nastou, D., Smyrniotis, V., & Arkadopoulos, N. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/906965 · Cited by 311
Clinical Aspects of Liver Transplantation
Mangus, R. S., & Tector, A. J. (2011) · Practical Hepatic Pathology: A Diagnostic Approach · doi:10.1016/b978-0-443-06803-4.00041-1 · Cited by 1
Metadata
- Authors
- Arroyo, V., Fernandez, J., & Ginès, P.
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2008-02
- Volume
- 28
- Issue
- 1
- Pages
- 081-095
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2035686295
- Cited by
- 210
- References
- 1
- FWCI
- 14.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathogenesis and Treatment of Hepatorenal Syndrome. https://app.cochat.ai/papers/10.1055/s-2008-1040323
- The paper
- Arroyo, V., Fernandez, J., & Ginès, P. (2008). Pathogenesis and Treatment of Hepatorenal Syndrome. Seminars in Liver Disease. https://doi.org/10.1055/s-2008-1040323
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.